ICD-11 classes
X Extension Codes
Substances
Medicaments
Agents primarily affecting blood constituents and immune...
Antineoplastic agents
XM1JG6 Monoclonal antibodies and antibody drug conjugates
XM9ND9 Programmed cell death protein 1/death ligand 1...

ICD-11 XM9ND9 Programmed cell death protein 1/death ligand 1 inhibitors

The diagnosis has no description.

The diagnosis includes nothing.

The diagnosis excludes nothing.

Diagnosis contains 5 clarifying diagnoses:

  1. XM3Q80 Tislelizumab
  2. XM2KA7 Retifanlimab
  3. XM0AN7 Oportuzumab monatox
  4. XM5Q93 Sacituzumab govitecan
  5. XM0550 Amivantamab

The diagnosis is coded elsewhere:

Search results